Mark Manfredi
Impact in
- Biological Psychiatry top 1%
- Tryptophan and brain disorders
- Cell Biology top 1%
- Microtubule and mitosis dynamics
Papers in
-
- Ubiquitin and proteasome pathways 9
- Protein Degradation and Inhibitors 4
- Cell Biology 25
- Microtubule and mitosis dynamics 24
- Co-authors
- Jeffrey Ecsedy (12 shared papers)Jessica J. Huck (15 shared papers)Mengkun Zhang (14 shared papers)Joseph B. Bolen (6 shared papers)Alexander J. Muller (1 shared paper)George C. Prendergast (1 shared paper)Yousef Zakharia (1 shared paper)Kara M. Hoar (6 shared papers)
- Journals
- Cancer Research (10 papers)Molecular Cancer Therapeutics (6 papers)Journal of Clinical Oncology (5 papers)Blood (4 papers)Cancer Chemotherapy and Pharmacology (4 papers)
- Partner nations
- United StatesJapanSpain
In The Last Decade
Mark Manfredi
57 papers receiving 3.7k citations
Mark Manfredi's Hit Papers
Peers
Comparison fields: 5 of 126
- Biological Psychiatry 255
- Cell Biology 973
- Oncology 1.1k
- Cancer Research 473
- Immunology and Allergy 166
Countries citing papers authored by Mark Manfredi
This map shows the geographic impact of Mark Manfredi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Manfredi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Manfredi more than expected).
Fields of papers citing papers by Mark Manfredi
This network shows the impact of papers produced by Mark Manfredi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Manfredi. The network helps show where Mark Manfredi may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Manfredi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 408 | |
| 2 | Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine Hit paper breakdown → | 2020 | 359 |
| 3 | 2007 | 336 | |
| 4 | 2010 | 272 | |
| 5 | 2019 | 262 | |
| 6 | 2011 | 246 | |
| 7 | 2018 | 201 | |
| 8 | 2017 | 184 | |
| 9 | 2001 | 180 | |
| 10 | 2001 | 174 | |
| 11 | 2012 | 130 | |
| 12 | 2010 | 104 | |
| 13 | 2014 | 100 | |
| 14 | 2015 | 87 | |
| 15 | 2011 | 77 | |
| 16 | 2010 | 66 | |
| 17 | 2011 | 55 | |
| 18 | 2011 | 49 | |
| 19 | Gangliosides influence angiogenesis in an experimental mouse brain tumor. | 1999 | 48 |
| 20 | 2015 | 42 |
About Mark Manfredi
Mark Manfredi is a scholar working on Molecular Biology, Cell Biology, Oncology, Biological Psychiatry and Cancer Research, having authored 58 papers that have together received 3.7k indexed citations. Recurring topics across this work include Microtubule and mitosis dynamics (24 papers), Ubiquitin and proteasome pathways (9 papers), Tryptophan and brain disorders (9 papers), Cancer-related Molecular Pathways (7 papers), Cancer Immunotherapy and Biomarkers (5 papers), Protein Degradation and Inhibitors (4 papers), Cancer Treatment and Pharmacology (4 papers) and Neuroblastoma Research and Treatments (4 papers). The work is most often cited by research in Biological Psychiatry (255 citations), Cell Biology (973 citations), Oncology (1.1k citations), Cancer Research (473 citations) and Immunology and Allergy (166 citations). Mark Manfredi has collaborated with scholars based in United States, Japan and Spain. Frequent co-authors include Jeffrey Ecsedy, Jessica J. Huck, Mengkun Zhang, Joseph B. Bolen, Alexander J. Muller, George C. Prendergast, Yousef Zakharia, Kara M. Hoar, Nello Mainolfi and Vipin Suri. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, Journal of Clinical Oncology, Blood and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.